MedTech Strategist, the industry's most trusted resource, will help you stay ahead of the opportunities and obstacles that are impacting your corporate strategy. We invite you to explore our coverage. Think Strategically. Subscribe Today .
Browse Latest Issue
C. Light Technologies is developing a high-resolution retinal imaging and eye tracking technology that can detect and analyze micron-scale movements in the back of the eye as a noninvasive means of assessing disease severity and progression in patients with multiple sclerosis and other neurological disorders.
IDbyDNA is "democratizing" the emerging field of metagenomics by marrying genomic sequencing with state-of-the-art computational sciences to bring rapid, cost-effective precision medicine to infectious disease testing. An example of its potential: rapid characterization of the SARS-CoV-2 virus.
New data presented at this year’s virtual TCT conference could help put to rest safety fears around the use of paclitaxel coated devices in the peripheral vasculature. That’s good news for medtech companies eager for a market recovery.